Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05562778 · ClinicalTrials.gov registry record · NA

Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

A NA study of Gynecologic Cancer and Hereditary Cancer Syndrome, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
4
Study locations

NCT05562778 is a NA study of Gynecologic Cancer and Hereditary Cancer Syndrome that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 150 participants, below the 762-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (80% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05562778, a NA study of Gynecologic Cancer and Hereditary Cancer Syndrome, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
4
Study locations

Study Summary

In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of harboring a familial cancer syndrome in an all-Medicaid gynecology clinic. Furthermore, the investigators aim to evaluate facilitators of inequity in regard to patient access to and utilization of genetic testing services.

Conditions Studied

Gynecologic Cancer Hereditary Cancer Syndrome

Interventions

  • OTHER Chatbot

Study Locations (4)

New York

  • NYP Brooklyn Methodist Hospital - Brooklyn
  • NYP Lower Manhattan Hospital - New York
  • Weill Cornell Medicine - New York
  • NYP Medical Group Queens - Queens

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-01-15
Est. Completion 2026-12
Phase NA

Sponsor

Weill Medical College of Cornell University

701 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05562778

The ClinicalTrials.gov registry entry for NCT05562778 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 762-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (80% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gynecologic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Chatbot is the first listed.

NCT05562778 reports 4 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05562778 about?

NCT05562778 is a clinical study titled "Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment". In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigators to determine if th...

What is the current status of trial NCT05562778?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-01-15. Estimated completion is 2026-12.

What conditions does trial NCT05562778 study?

This clinical trial studies the following conditions: Gynecologic Cancer, Hereditary Cancer Syndrome.

What interventions are being tested in trial NCT05562778?

The interventions under investigation include: Chatbot (OTHER).

Who is sponsoring clinical trial NCT05562778?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05562778 being conducted?

This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gynecologic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gynecologic Cancer

All registered trials for this condition

Hereditary Cancer Syndrome

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.